• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Moerae Matrix

edit

Moerae Matrix is a privately held biopharmaceutical company focused on the development of first-in-class targeted therapeutics for fibrotic diseases.

Milestones

edit

• 
  Moerae Matrix added Cynthia Lander as Chairman and CEO.
  Posted 2/3/13 at 10:29pm
• 
  Moerae Matrix received $5.53M in Series B funding. (1/10/13)
  Posted 2/3/13 at 10:29pm via sec.gov

Videos

Screenshots

edit

Sources

1. Edgar Report (sec.gov) [edit]